November 9, 2026

Network Bio partners with Duke University on AI disease models

​Network Bio has entered into a research collaboration with Duke University to develop AI models of human disease using biospecimens...

November 9, 2026

OncoC4 announces positive Phase I/II findings for cesalatamig in NSCLC

​OncoC4 has reported positive findings from Phase I/II trials of its investigational bispecific antibody, cesalatamig, as a monotherapy in patients...

November 9, 2026

GL Capital and Zylox-Tonbridge to invest $189m in LifeTech

​Lighthouse Two will subscribe for shares representing 16.7% of LifeTech's share capital.The post GL Capital and Zylox-Tonbridge to invest $189m...

November 6, 2026

GeneDx and Mirum to provide genetic tests for cholestasis, cataracts or PBD-ZSD

​GeneDx and Mirum Pharmaceuticals have partnered to provide no-cost exome sequencing for eligible patients across cholestasis, early-onset cataracts, and PBD-ZSD...

November 6, 2026

Mondego Bio begins Phase Ia trial of oral MB‑388

​Mondego Bio has started a first-in-human Phase Ia clinical trial of MB 388, which is designed to act in both...

November 6, 2026

Alfasigma receives EC’s expanded approval for filgotinib to treat axSpA

​Alfasigma has received the EC's expanded approval for Jyseleca to treat adult patients living with active axial spondyloarthritis (axSpA).The post...

November 5, 2026

Laza Medical secures $160m to advance robotic imaging system

​Laza Medical has secured up to $160m in a Series B structured financing round to advance robotic imaging technology for...

November 5, 2026

Tango and Erasca’s Phase I/II trial of ERAS-0015 combo opens for enrolment

​Tango Therapeutics and Erasca have begun enrolment for a Phase I/II trial assessing the combination of oral therapies ERAS-0015 and...

November 5, 2026

PharmatrophiX and Circular partner on neurodegenerative drugs

​PharmatrophiX and Circular Genomics have partnered to advance blood-based circular RNA biomarkers in neurodegenerative drug development programmes.The post PharmatrophiX and...

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.